Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Precision Medicine in Infectious Disease Publisher



Alvarez MJR1 ; Hasanzad M2, 3 ; Sarhangi N3 ; Meybodi HRA4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Istituto Superiore di Sanita, Rome, Italy
  2. 2. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  3. 3. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Precision Medicine in Clinical Practice Published:2022


Abstract

The conception that several infectious diseases were linked to an inherited disorder has been discussed, and every day, substantial evidence now is supported by the human genetic contribution to susceptibility to infectious diseases. Despite being a forerunner, personalized medicine (PM) is not yet routinely applied in infectious patient care. For this scope, education is a crucial step for the successful implementation of PM in the clinic, and with this part, we would like to encourage learning about PM in the communicable disease field. The information in this section will drive you through the concept of personalized infectious diseases and a piece of basic knowledge about the possibility of identifying determinants of clinical outcomes, looking at the host face through selected infectious diseases which are considered a global health issue such as HIV (human immunodeficiency virus) infection and related AIDS (acquired immunodeficiency syndrome), infections caused by Mycobacterium tuberculosis, malaria, and COVID-19 infection. It is especially important, as it can enable the development of one’s own thoughts and ideas to be able to understand and implement this rapidly developing field of science. A brief overview of the genetic identification of more vulnerable individuals is expected to inform personalized treatment and perhaps vaccination strategies. Additionally, new technologies are supporting the rapid identification of infective agents and targeted approaches based on the genetic resistance of pathogens to antibiotics. This information can lead to revising the data that can be used for personalized predicting diseases, improving personalized treatment, and also personalized prevention strategies specific to infectious pathogens. The last subchapter is dedicated to a deeper revision of the COVID-19 infection from a personalized medicine perspective. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.
Related Docs
View other Related Docs
1. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
2. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
3. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
4. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
5. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
6. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
7. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
8. Serological and Molecular Tests for Covid-19: A Recent Update, Iranian Journal of Immunology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (30)
Seyed Ahmad Seyed Alinaghi (7)
Other Related Docs
9. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
10. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
11. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
12. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
13. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
14. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
15. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
16. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
17. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
18. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
19. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
20. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
21. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
22. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
23. Design of Novel Disturbing Peptides Against Ace2 Sars-Cov-2 Spike-Binding Region by Computational Approaches, Frontiers in Pharmacology (2022)
24. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
25. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
26. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
27. Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients, Future Microbiology (2020)
28. Sars-Cov-2 Outbreak in Iran: The Dynamics of the Epidemic and Evidence on Two Independent Introductions, Transboundary and Emerging Diseases (2022)
29. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
30. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)
31. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
32. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)
33. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
34. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
35. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
36. Evolutionary Study of Covid-19, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) As an Emerging Coronavirus: Phylogenetic Analysis and Literature Review, Veterinary Medicine and Science (2021)
37. Point-Of-Use Rapid Detection of Sars-Cov-2: Nanotechnology-Enabled Solutions for the Covid-19 Pandemic, International Journal of Molecular Sciences (2020)
38. The Promising Approach of Mscs Therapy for Covid-19 Treatment, Cell and Tissue Banking (2023)
39. A Comprehensive Review of Histopathological Findings of Infections Induced by Covid-19, Cellular and Molecular Biology (2020)
40. Design of an Engineered Ace2 As a Novel Therapeutics Against Covid-19, Journal of Theoretical Biology (2020)
41. Insights Into the Sars-Cov2 Outbreak; the Great Global Challenge: A Mini Review, Journal of Cellular and Molecular Anesthesia (2020)
42. Sars-Cov-2 in Brief: From Virus to Prevention, Osong Public Health and Research Perspectives (2022)
43. Photobiomodulation and Antiviral Photodynamic Therapy in Covid-19 Management, Advances in Experimental Medicine and Biology (2021)
44. Characterization of Sars-Cov-2 Different Variants and Related Morbidity and Mortality: A Systematic Review, European Journal of Medical Research (2021)
45. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
46. Naringenin, a Flavanone With Antiviral and Anti-Inflammatory Effects: A Promising Treatment Strategy Against Covid-19, Phytotherapy Research (2020)
47. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
48. Comparison of Sars-Cov-2 (Coronavirus) With Other Similar Viruses Based on Current Evidence, Journal of Iranian Medical Council (2022)
49. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
50. Implementation of an In-House Platform for Rapid Screening of Sars-Cov-2 Genome Variations, Archives of Iranian Medicine (2023)